INTELLIGENT LIVING APPLICATI (ILAG)

KYG4804S1012 - Common Stock

0.857  +0.01 (+1.42%)

Premarket: 0.9 +0.04 (+5.02%)

Fundamental Rating

2

Taking everything into account, ILAG scores 2 out of 10 in our fundamental rating. ILAG was compared to 40 industry peers in the Building Products industry. ILAG scores quite bad on profitability, while its financial health is fine. Not spectacular, but in line with the averages. ILAG has a expensive valuation and it also scores bad on growth.



1

1. Profitability

1.1 Basic Checks

In the past year ILAG has reported negative net income.
ILAG had a negative operating cash flow in the past year.
In the past 5 years ILAG always reported negative net income.
In the past 5 years ILAG always reported negative operating cash flow.

1.2 Ratios

With a Return On Assets value of -19.15%, ILAG is not doing good in the industry: 90.00% of the companies in the same industry are doing better.
ILAG's Return On Equity of -21.35% is on the low side compared to the rest of the industry. ILAG is outperformed by 82.50% of its industry peers.
Industry RankSector Rank
ROA -19.15%
ROE -21.35%
ROIC N/A
ROA(3y)-13.9%
ROA(5y)-13.76%
ROE(3y)-23.27%
ROE(5y)-24.79%
ROIC(3y)N/A
ROIC(5y)N/A

1.3 Margins

ILAG has a Gross Margin of 9.83%. This is amonst the worse of the industry: ILAG underperforms 92.50% of its industry peers.
ILAG's Gross Margin has improved in the last couple of years.
The Profit Margin and Operating Margin are not available for ILAG so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 9.83%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-11.29%
GM growth 5Y7.66%

6

2. Health

2.1 Basic Checks

ILAG does not have a ROIC to compare to the WACC, probably because it is not profitable.
The number of shares outstanding for ILAG remains at a similar level compared to 1 year ago.
The number of shares outstanding for ILAG remains at a similar level compared to 5 years ago.
ILAG has a better debt/assets ratio than last year.

2.2 Solvency

ILAG has an Altman-Z score of 4.75. This indicates that ILAG is financially healthy and has little risk of bankruptcy at the moment.
ILAG has a Altman-Z score (4.75) which is in line with its industry peers.
A Debt/Equity ratio of 0.02 indicates that ILAG is not too dependend on debt financing.
Looking at the Debt to Equity ratio, with a value of 0.02, ILAG belongs to the top of the industry, outperforming 82.50% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.02
Debt/FCF N/A
Altman-Z 4.75
ROIC/WACCN/A
WACC10.69%

2.3 Liquidity

A Current Ratio of 8.70 indicates that ILAG has no problem at all paying its short term obligations.
ILAG has a better Current ratio (8.70) than 92.50% of its industry peers.
A Quick Ratio of 5.09 indicates that ILAG has no problem at all paying its short term obligations.
With an excellent Quick ratio value of 5.09, ILAG belongs to the best of the industry, outperforming 95.00% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 8.7
Quick Ratio 5.09

0

3. Growth

3.1 Past

The earnings per share for ILAG have decreased strongly by -85.31% in the last year.
The Revenue for ILAG has decreased by -66.96% in the past year. This is quite bad
Measured over the past years, ILAG shows a very negative growth in Revenue. The Revenue has been decreasing by -14.88% on average per year.
EPS 1Y (TTM)-85.31%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%58.87%
Revenue 1Y (TTM)-66.96%
Revenue growth 3Y-16.88%
Revenue growth 5Y-14.88%
Sales Q2Q%-62.92%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.

0

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for ILAG. In the last year negative earnings were reported.
Industry RankSector Rank
PE N/A
Fwd PE N/A

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

0

5. Dividend

5.1 Amount

ILAG does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

INTELLIGENT LIVING APPLICATI

NASDAQ:ILAG (1/14/2025, 8:00:02 PM)

Premarket: 0.9 +0.04 (+5.02%)

0.857

+0.01 (+1.42%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCapital Goods
GICS IndustryBuilding Products
Earnings (Last)11-29 2022-11-29/bmo
Earnings (Next)N/A N/A
Inst Owners0.72%
Inst Owner Change0%
Ins Owners51.83%
Ins Owner ChangeN/A
Market Cap15.48M
AnalystsN/A
Price TargetN/A
Short Float %1.14%
Short Ratio3.99
Dividend
Industry RankSector Rank
Dividend Yield N/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 2.4
P/FCF N/A
P/OCF N/A
P/B 0.94
P/tB 0.94
EV/EBITDA N/A
EPS(TTM)-0.19
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)-0.25
FCFYN/A
OCF(TTM)-0.18
OCFYN/A
SpS0.36
BVpS0.91
TBVpS0.91
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -19.15%
ROE -21.35%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 9.83%
FCFM N/A
ROA(3y)-13.9%
ROA(5y)-13.76%
ROE(3y)-23.27%
ROE(5y)-24.79%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-11.29%
GM growth 5Y7.66%
F-Score2
Asset Turnover0.35
Health
Industry RankSector Rank
Debt/Equity 0.02
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 196.14%
Cap/Sales 21.11%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 8.7
Quick Ratio 5.09
Altman-Z 4.75
F-Score2
WACC10.69%
ROIC/WACCN/A
Cap/Depr(3y)531.11%
Cap/Depr(5y)342.82%
Cap/Sales(3y)18.52%
Cap/Sales(5y)11.7%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-85.31%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%58.87%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-66.96%
Revenue growth 3Y-16.88%
Revenue growth 5Y-14.88%
Sales Q2Q%-62.92%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-47.6%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y45.83%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y24.14%
OCF growth 3YN/A
OCF growth 5YN/A